Cargando…

Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study

BACKGROUND: Differentiated thyroid cancer (DTC) often seriously impacts patients’ lives. Radionuclide Iodine-131 ((131)I) is widely used in treating patients with DTC. However, most patients know little about radionuclide therapy, and the treatment needs to be performed in a special isolation ward,...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ying-Rui, Yu, Xiao-Peng, Huang, Li-Qun, Xie, Long, Zha, Jin-Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401505/
https://www.ncbi.nlm.nih.gov/pubmed/37547735
http://dx.doi.org/10.5498/wjp.v13.i7.486
_version_ 1785084679825653760
author Su, Ying-Rui
Yu, Xiao-Peng
Huang, Li-Qun
Xie, Long
Zha, Jin-Shun
author_facet Su, Ying-Rui
Yu, Xiao-Peng
Huang, Li-Qun
Xie, Long
Zha, Jin-Shun
author_sort Su, Ying-Rui
collection PubMed
description BACKGROUND: Differentiated thyroid cancer (DTC) often seriously impacts patients’ lives. Radionuclide Iodine-131 ((131)I) is widely used in treating patients with DTC. However, most patients know little about radionuclide therapy, and the treatment needs to be performed in a special isolation ward, which can cause anxiety and depression. AIM: To explore anxiety and depression status and their influencing factors after (131)I treatment in patients with DTC. METHODS: A questionnaire survey was conducted among postoperative patients with DTC who received (131)I treatment at our hospital from June 2020 to December 2022. General patient data were collected using a self-administered demographic characteristics questionnaire. The self-rating depression scale and self-rating anxiety scale were used to determine whether patients were worried about their symptoms and the degree of anxiety and depression. The patients were cate-gorized into anxiety, non-anxiety, depression, and non-depression groups. Single-variable and multiple-variable analyses were used to determine the risk factors for anxiety and depression in patients with thyroid cancer after surgery. RESULTS: A total of 144 patients were included in this study. The baseline mean score of self-rating anxiety and depression scales were 50.06 ± 16.10 and 50.96 ± 16.55, respectively. Notably, 48.62% (70/144) had anxiety and 47.22% (68/144) of the patients had depression. Sex, age, education level, marital status, household income, underlying diseases, and medication compliance significantly differed among groups (P < 0.05). Furthermore, multivariate logistic regression analysis showed that education level, per capita monthly household income, and medication compliance level affected anxiety (P = 0.015, 0.001, and 0.001 respectively. Patient’s sex, marital status, and underlying diseases affected depression (P = 0.007, 0.001, and 0.009, respectively). CONCLUSION: Nursing interventions aiming at reducing the risk of anxiety and depression should target unmarried female patients with low education level, low family income, underlying diseases, and poor adherence to medications.
format Online
Article
Text
id pubmed-10401505
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-104015052023-08-05 Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study Su, Ying-Rui Yu, Xiao-Peng Huang, Li-Qun Xie, Long Zha, Jin-Shun World J Psychiatry Observational Study BACKGROUND: Differentiated thyroid cancer (DTC) often seriously impacts patients’ lives. Radionuclide Iodine-131 ((131)I) is widely used in treating patients with DTC. However, most patients know little about radionuclide therapy, and the treatment needs to be performed in a special isolation ward, which can cause anxiety and depression. AIM: To explore anxiety and depression status and their influencing factors after (131)I treatment in patients with DTC. METHODS: A questionnaire survey was conducted among postoperative patients with DTC who received (131)I treatment at our hospital from June 2020 to December 2022. General patient data were collected using a self-administered demographic characteristics questionnaire. The self-rating depression scale and self-rating anxiety scale were used to determine whether patients were worried about their symptoms and the degree of anxiety and depression. The patients were cate-gorized into anxiety, non-anxiety, depression, and non-depression groups. Single-variable and multiple-variable analyses were used to determine the risk factors for anxiety and depression in patients with thyroid cancer after surgery. RESULTS: A total of 144 patients were included in this study. The baseline mean score of self-rating anxiety and depression scales were 50.06 ± 16.10 and 50.96 ± 16.55, respectively. Notably, 48.62% (70/144) had anxiety and 47.22% (68/144) of the patients had depression. Sex, age, education level, marital status, household income, underlying diseases, and medication compliance significantly differed among groups (P < 0.05). Furthermore, multivariate logistic regression analysis showed that education level, per capita monthly household income, and medication compliance level affected anxiety (P = 0.015, 0.001, and 0.001 respectively. Patient’s sex, marital status, and underlying diseases affected depression (P = 0.007, 0.001, and 0.009, respectively). CONCLUSION: Nursing interventions aiming at reducing the risk of anxiety and depression should target unmarried female patients with low education level, low family income, underlying diseases, and poor adherence to medications. Baishideng Publishing Group Inc 2023-07-19 /pmc/articles/PMC10401505/ /pubmed/37547735 http://dx.doi.org/10.5498/wjp.v13.i7.486 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Observational Study
Su, Ying-Rui
Yu, Xiao-Peng
Huang, Li-Qun
Xie, Long
Zha, Jin-Shun
Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
title Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
title_full Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
title_fullStr Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
title_full_unstemmed Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
title_short Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
title_sort factors influencing postoperative anxiety and depression following iodine-131 treatment in patients with differentiated thyroid cancer: a cross-sectional study
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401505/
https://www.ncbi.nlm.nih.gov/pubmed/37547735
http://dx.doi.org/10.5498/wjp.v13.i7.486
work_keys_str_mv AT suyingrui factorsinfluencingpostoperativeanxietyanddepressionfollowingiodine131treatmentinpatientswithdifferentiatedthyroidcanceracrosssectionalstudy
AT yuxiaopeng factorsinfluencingpostoperativeanxietyanddepressionfollowingiodine131treatmentinpatientswithdifferentiatedthyroidcanceracrosssectionalstudy
AT huangliqun factorsinfluencingpostoperativeanxietyanddepressionfollowingiodine131treatmentinpatientswithdifferentiatedthyroidcanceracrosssectionalstudy
AT xielong factorsinfluencingpostoperativeanxietyanddepressionfollowingiodine131treatmentinpatientswithdifferentiatedthyroidcanceracrosssectionalstudy
AT zhajinshun factorsinfluencingpostoperativeanxietyanddepressionfollowingiodine131treatmentinpatientswithdifferentiatedthyroidcanceracrosssectionalstudy